<< Back

Innophos Appoints Robert Sklans as SVP, Chief Human Resources Officer

CRANBURY, N.J.--(BUSINESS WIRE)--Feb. 20, 2018-- Innophos Holdings, Inc. (NASDAQ:IPHS) announced today that the Board of Directors has appointed Robert Sklans as SVP, Chief Human Resources Officer. Sklans will have responsibility for driving the Company's global human resources strategy and will report to Innophos’ Chairman, President and Chief Executive Officer, Kim Ann Mink, Ph.D. He will also become a member of the Company’s Executive Leadership Council.

A seasoned executive leader, Sklans has more than 20 years of experience serving the health care, medical device, consumer product, specialty chemical and technology industries. He comes to Innophos from Elementis, where he served as CHRO and led the global HR function, while also serving as Supervisory Board Member for Elementis Specialties, Netherlands BV. Before joining Elementis, Sklans served as VP of HR, North America (NA) Region for Royal DSM, leading an HR organization of more than 50 people. Earlier, he was Director of Talent Management, NA Region, for Evonik Industries. Sklans also served in a variety of leadership roles for Johnson & Johnson, the last as a Director, Global Talent Management, for Medical Device & Diagnostics.

Sklans has an extensive background in partnering with businesses and developing organizational capabilities across various companies. With a history of strong functional expertise supporting businesses in both growth and restructuring modes, he has vast experience with change management, talent development and employee engagement. Sklans also has successfully led HR due diligence and post-merger integration of acquisitions.

“We are very pleased, and fortunate, to welcome Rob to the Innophos team,” said Kim Ann Mink, Ph.D. “Bringing in an executive of Rob’s caliber ideally aligns with our Vision 2022 strategic goals and demonstrates our continued commitment to excellence. With his proven leadership and drive for innovative practices and high standards, I am confident he will build on our talented and diverse global workforce, and bring a unique perspective to our growing organization.”

“It is a privilege to be joining Innophos at such an exciting time, and to partake in shaping the future of an organization where people are so highly respected and deemed such an important part of its success,” said Sklans. “I look forward to helping advance the Company, and its employees, through its accelerated growth and transformational journey.”

Rob earned an MA in Organizational Psychology from Columbia University and a BA in Psychology from Connecticut College.

About the Company

Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral, enzyme and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. In 2017 Innophos acquired Novel Ingredients and NutraGenesis, further expanding its food, health and nutrition platform. For more information, please visit www.innophos.com. 'IPHS-G'

Safe Harbor for Forward-Looking and Cautionary Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.

Source: Innophos Holdings, Inc.

Mark Feuerbach, 609-366-1204
Sharon Merrill Associates
Ryan Flaim, 617-542-5300